Biological Insights into Chemotherapy Resistance in Ovarian Cancer

Biological Insights into Chemotherapy Resistance in Ovarian Cancer

The majority of patients with high-grade serous ovarian cancer (HGSOC) initially respond to chemotherapy; however, most will develop chemotherapy resistance. Gene signatures may change with the development of chemotherapy resistance in this population, which is important as it may lead to tailored t...

Full description

Bibliographic Details
Main Authors: Michelle A. Glasgow, Peter Argenta, Juan E. Abrahante, Mihir Shetty, Shobhana Talukdar, Paula A. Croonquist, Mahmoud A. Khalifa, Timothy K. Starr
Format: Article
Language:English
Published: MDPI AG 2019-04-01
Series:International Journal of Molecular Sciences
Subjects:
ovarian cancer
chemotherapy resistance
gene expression
Online Access:https://www.mdpi.com/1422-0067/20/9/2131

Internet

https://www.mdpi.com/1422-0067/20/9/2131

Similar Items